Algumas polêmicas envolvendo a utilização de células-tronco embrionárias no Brasil: um desafio à inovação jurisdicional

• Autor(a) principal: Moraes, Rogério
• Data de Publicação: 2011
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional do FGV (FGV Repositório Digital)
• Texto Completo: https://hdl.handle.net/10438/9605
• topic: Innovation jurisdictional; Biolaw; Bioethics; Patenting; Células-tronco embrionárias; Inovação jurisdicional; Biodireito; Bioética; Patenteamento; Direito; Direito e biologia; Bioética; Células-tronco embrionárias

The purpose of this dissertation is the examination of some of the many ethical and legal controversies involving the use of human embryonic stem cells for research and therapy. The use of such stem cells was approved by Law nº. 11.105 of 2005, known as the new Biosecurity Law, article 5 of which allowed only for research and therapy, the use of said cells obtained from human embryos from the in vitro fertilization process, not used in their procedure, met certain conditions. Once came into effect, the device has been cited by the Attorney General of the Direct Action of Unconstitutionality (ADI) nº. 3510, which generated extensive discussions within the multidisciplinary team. Despite the declaration of the constitutionality of that article, there are still many controversial legal and ethical. It is questionable, especially, the differences concerning the legal status of the embryo produced in vitro and surplus in the process of fertilization, as well as the adequacy of the constitutional principle of human dignity in this context. Are shown, though, questions relevant to the patenting of genetic material and, consequently, of embryonic stem cells.